Genetic testing of etiology of intellectual disability in a dedicated physical healthcare outpatient clinic for adults with intellectual disability.

Author information

Abstract

BACKGROUND:

No guidelines exist for assessment of etiology of intellectual disability in adults with intellectual disability by adult physicians, though robust guidelines exist for paediatric populations. It was speculated that the paediatric guidelines would also be suitable for adults.

AIMS:

In rural/regional setting with limited clinical genetics, to perform a quality assurance evaluation on genetics assessment of etiology of developmental disability in adults attending a dedicated healthcare clinic for adults with intellectual disability, compare results with paediatric standards, speculate if these seem appropriate for adults, and speculate on a role for clinical genetics services.

METHODS:

Retrospective chart audit of eligible patients looking at genetic clinical assessment, tests selected (molecular karyotype, G banding, metabolics), and yield of positive results. The results were compared to the recommended paediatric guidelines..

RESULTS:

Of 117 eligible adult patients, ideal genetic history was incomplete for 40% of patients without Down syndrome because of physician cause and lack of information. The number of abnormal genetic results increased from 46% to 66%, mainly from the molecular karyotype, though not all may have been clinically relevant. The improved yield from this test was similar to that in paediatric studies. Use of G banding and metabolic testing could be refined.

CONCLUSION:

Improvement can be made in clinical genetic assessment, but results generally support use of molecular karyotyping as first tier testing of cause of unknown intellectual disability in adults, as in the case for paediatric populations. The study highlights a necessary complementary role for clinical geneticists to interpret abnormal results.